| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $25.8M | $26.9M | $24.1M |
| YoY Revenue Growth % | -4.1% | +11.5% | — |
| Gross Profit | $7.3M | $6.1M | — |
| Gross Margin % | 28.3% | 22.5% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | -$1.9M | -$2.4M | -$4.9M |
| Operating Margin % | -7.4% | -9.0% | -20.2% |
| Net Income (GAAP) | -$1.6M | -$1.9M | -$4.2M |
| EBITDA (Normalized) | -$1.9M | -$2.3M | — |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | -$3.7M | -$1.5M | -$206.0K |
| Capital Expenditures (CapEx) | $48.0K | $106.0K | — |
| Free Cash Flow (FCF) | -$3.7M | -$1.6M | -$206.0K |
| FCF Margin % | -14.4% | -5.9% | -0.9% |
| Return on Invested Capital (ROIC %) | -9.4% | -14.7% | — |
| Cash & Short-Term Equivalents | $8.7M | $12.6M | — |
| Total Debt (Short + Long Term) | — | $181.0K | — |
| Total Stockholders' Equity | $24.7M | $25.4M | — |